A New Insight on Feasibility of Pre-, Pro-, and Synbiotics-based Therapies in Alzheimer’s Disease

Author(s):
Marjan TalebiMarjan TalebiMarjan Talebi ORCID1, Vida EbrahimiVida EbrahimiVida Ebrahimi ORCID2,*, Ahmadreza RasouliAhmadreza RasouliAhmadreza Rasouli ORCID3, 4, Afsaneh FarjamiAfsaneh Farjami5, 6, Saiedeh Razi-SoofiyaniSaiedeh Razi-SoofiyaniSaiedeh Razi-Soofiyani ORCID7, 8, Alireza SoleimanianAlireza Soleimanian6, Haleh ForouhandehHaleh Forouhandeh9, Vahideh TarhrizVahideh TarhrizVahideh Tarhriz ORCID8
1Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3Department of Nutrition, School of Health, Qazvin University of Medical Sciences, Qazvin, Iran
4Student Research Committee, School of Health, Qazvin, University of Medical Sciences, Qazvin, Iran
5Food and Drug Safety Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
6Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
7Clinical Research Development Unit, Sina Educational, Research and Treatment Center, Tabriz University of Medical Sciences, Tabriz, Iran
8Molecular Medicine Research Center, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
9Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran

Journal of Reports in Pharmaceutical Sciences:Vol. 11, issue 2; 141-55
Published online:Dec 23, 2022
Article type:Research Article
Received:Dec 05, 2021
Accepted:May 21, 2022
How to Cite:Talebi M, Ebrahimi V, Rasouli A, Farjami A, Razi-Soofiyani S, et al. A New Insight on Feasibility of Pre-, Pro-, and Synbiotics-based Therapies in Alzheimer’s Disease. J Rep Pharm Sci. 2022;11(2):e146232. doi: https://doi.org/10.4103/jrptps.JRPTPS_170_21

Abstract

Similar Articles

19
Aug
2024
Arch Clin Infect Dis

Assessment of Enterobacter, Clostridium, Lactobacillus, and Bifidobacterium Population in a Mouse Model of Alzheimer's Disease

Pariya Mehrbakhsh,
Akram Sadat Tabatabaee Bafroee,
Elahe Aliasgari

Mehrbakhsh P, Tabatabaee Bafroee AS, Aliasgari E. Assessment of Enterobacter, Clostridium, Lactobacillus, and Bifidobacterium Population in a Mouse Model of Alzheimer's Disease. Arch Clin Infect Dis. 2024;19(4):e138798. doi: https://doi.org/10.5812/archcid-138798

22
Apr
2018
The Effect of Synbiotic as an Adjuvant Therapy to Fluoxetine in Moderate Depression: A Randomized Multicenter Trial

The Effect of Synbiotic as an Adjuvant Therapy to Fluoxetine in Moderate Depression: A Randomized Multicenter Trial

Zeinab Ghorbani,
Sara Nazari,
Farnaz Etesam,
Saeedeh Nourimajd,
Mohammad Ahmadpanah,
Soodeh Razeghi Jahromi

Ghorbani Z, Nazari S, Etesam F, Nourimajd S, Ahmadpanah M, et al. The Effect of Synbiotic as an Adjuvant Therapy to Fluoxetine in Moderate Depression: A Randomized Multicenter Trial. Arch Neurosci. 2018;5(2):e60507. doi: https://doi.org/10.5812/archneurosci.60507

5
Mar
2022

Role of microRNA as a biomarker in Alzheimer’s disease

Adele jafari,
Behrooz Khakpour Taleghani,
Parvaneh Keshavarz,
Mohammad Akhoondian,
leila alidoust

jafari A, Khakpour Taleghani B, Keshavarz P, Akhoondian M, alidoust L. Role of microRNA as a biomarker in Alzheimer’s disease. koomesh. 2022;24(1):e152385. doi:

2
Mar
2025
J Microbiota

The Effect of Probiotic Supplementation in Alleviating Symptoms of Five Major Mental Illnesses: A Comprehensive Review

Mahdi Soltanian,
Amirhossein Rajabalinejad,
Rasool Rajabi,
Mir-Michael Mousavi

Soltanian M, Rajabalinejad A, Rajabi R, Mousavi M. The Effect of Probiotic Supplementation in Alleviating Symptoms of Five Major Mental Illnesses: A Comprehensive Review. J Microbiota. 2025;2(1):e159824. doi: https://doi.org/10.5812/jmb-159824

16
Aug
2022
Iran J Pharm Res

Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases

Parham Pooladgar,
Mehdi Sakhabakhsh,
Arsia Taghva,
Saeed Soleiman-Meigooni

Pooladgar P, Sakhabakhsh M, Taghva A, Soleiman-Meigooni S. Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases. Iran J Pharm Res. 2022;21(1):e128408. doi: https://doi.org/10.5812/ijpr-128408


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles